The University of Southampton
University of Southampton Institutional Repository

The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease

The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease
The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease
Background and Aims: several susceptibility gene variants predisposing to nonalcoholic fatty liver disease (NAFLD) have been identified in chronic kidney disease (CKD). Evidence supports that 17-beta hydroxysteroid dehydrogenase 13 (HSD17B13) rs72613567 plays a role in NAFLD development by affecting lipid homeostasis. Since lipid droplets may accumulate in the kidneys and contribute to renal injury, we investigated the association between the HSD17B13 rs72613567 variant and markers of renal function/injury in NAFLD.

Methods and Results: we measured estimated glomerular filtration rate (eGFR), urinary/serum neutrophil gelatinase-associated lipocalin (NGAL), and urinary albumin-to-creatinine ratio (u-ACR) in individuals with biopsy-proven NAFLD. Multivariable regression analyses were undertaken to examine the associations between the HSD17B13 rs72613567 variant and markers of renal function/injury. Individuals were stratified by HSD17B13 rs72613567 genotypes into -/-, A/- and A/A groups. HSD17B13 rs72613567 genotypes were not significantly associated with eGFR and urinary/serum NGAL levels. Conversely, the prevalence of abnormal albuminuria in the A/- + A/A group was lower than in the -/- group (4.92% vs. 19.35%, p=0.001). Additionally, the mean u-ACR levels were lower among carriers of the A/- or A/A genotypes with coexisting hypertension or diabetes, than among those with the -/- genotype. The risk of abnormal albuminuria (adjusted-odds ratio 0.16, p=0.001) remained significantly lower in the A/- + A/A group after adjustment for established renal risk factors and histologic severity of NAFLD.

Conclusion: HSD17B13 rs72613567: A allele is associated with a lower risk of having abnormal albuminuria, but not with lower eGFR or urinary/serum NGAL levels, in patients with biopsy-proven NAFLD.

17-Beta hydroxysteroid dehydrogenase 13, Albuminuria, Chronic kidney disease, Liver biopsy, Nonalcoholic fatty liver disease
0939-4753
1822-1831
Sun, Dan-Qin
0d1599b1-accf-4668-a877-b4c5f7fc925f
Wang, Ting-Yao
08582671-11f5-4881-b1da-133b657b9e72
Zheng, Kenneth I.
b7ec18e2-ec41-4447-ab84-2203c35963c9
Zhang, Hao-Yang
249aac83-465c-413b-84a5-130437f0b978
Wang, Xiao-Dong
feb0a463-3204-4b24-a110-533d591a214c
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Chen, Yong-Ping
b2bceda5-a553-4aa8-b5bd-2b0c0bf95650
Yuan, Wei-Jie
2256040f-f7bc-4f3f-bee3-c48a8aa37c15
Jin, Yan
b891bd09-7224-46c3-ba68-40fa6c67255e
Zheng, Ming-Hua
47732ddf-1ace-4e53-9e91-eeed56709a32
Sun, Dan-Qin
0d1599b1-accf-4668-a877-b4c5f7fc925f
Wang, Ting-Yao
08582671-11f5-4881-b1da-133b657b9e72
Zheng, Kenneth I.
b7ec18e2-ec41-4447-ab84-2203c35963c9
Zhang, Hao-Yang
249aac83-465c-413b-84a5-130437f0b978
Wang, Xiao-Dong
feb0a463-3204-4b24-a110-533d591a214c
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Chen, Yong-Ping
b2bceda5-a553-4aa8-b5bd-2b0c0bf95650
Yuan, Wei-Jie
2256040f-f7bc-4f3f-bee3-c48a8aa37c15
Jin, Yan
b891bd09-7224-46c3-ba68-40fa6c67255e
Zheng, Ming-Hua
47732ddf-1ace-4e53-9e91-eeed56709a32

Sun, Dan-Qin, Wang, Ting-Yao, Zheng, Kenneth I., Zhang, Hao-Yang, Wang, Xiao-Dong, Targher, Giovanni, Byrne, Christopher, Chen, Yong-Ping, Yuan, Wei-Jie, Jin, Yan and Zheng, Ming-Hua (2021) The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. Nutrition, Metabolism & Cardiovascular Diseases, 31 (6), 1822-1831. (doi:10.1016/j.numecd.2021.02.018).

Record type: Article

Abstract

Background and Aims: several susceptibility gene variants predisposing to nonalcoholic fatty liver disease (NAFLD) have been identified in chronic kidney disease (CKD). Evidence supports that 17-beta hydroxysteroid dehydrogenase 13 (HSD17B13) rs72613567 plays a role in NAFLD development by affecting lipid homeostasis. Since lipid droplets may accumulate in the kidneys and contribute to renal injury, we investigated the association between the HSD17B13 rs72613567 variant and markers of renal function/injury in NAFLD.

Methods and Results: we measured estimated glomerular filtration rate (eGFR), urinary/serum neutrophil gelatinase-associated lipocalin (NGAL), and urinary albumin-to-creatinine ratio (u-ACR) in individuals with biopsy-proven NAFLD. Multivariable regression analyses were undertaken to examine the associations between the HSD17B13 rs72613567 variant and markers of renal function/injury. Individuals were stratified by HSD17B13 rs72613567 genotypes into -/-, A/- and A/A groups. HSD17B13 rs72613567 genotypes were not significantly associated with eGFR and urinary/serum NGAL levels. Conversely, the prevalence of abnormal albuminuria in the A/- + A/A group was lower than in the -/- group (4.92% vs. 19.35%, p=0.001). Additionally, the mean u-ACR levels were lower among carriers of the A/- or A/A genotypes with coexisting hypertension or diabetes, than among those with the -/- genotype. The risk of abnormal albuminuria (adjusted-odds ratio 0.16, p=0.001) remained significantly lower in the A/- + A/A group after adjustment for established renal risk factors and histologic severity of NAFLD.

Conclusion: HSD17B13 rs72613567: A allele is associated with a lower risk of having abnormal albuminuria, but not with lower eGFR or urinary/serum NGAL levels, in patients with biopsy-proven NAFLD.

Text
R1-manuscript - Accepted Manuscript
Download (369kB)
Text
R1-Table 1 - Accepted Manuscript
Download (227kB)
Text
R1-Table 2 - Accepted Manuscript
Download (170kB)
Text
R1-Table 3 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
R1-Table 4 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Image
R1-Figure 1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Image
R1-Figure 2 - Accepted Manuscript
Restricted to Repository staff only
Request a copy

Show all 7 downloads.

More information

Accepted/In Press date: 16 February 2021
e-pub ahead of print date: 25 February 2021
Published date: 7 June 2021
Additional Information: NIHR So'ton BRC affiliated, Chris Byrne
Keywords: 17-Beta hydroxysteroid dehydrogenase 13, Albuminuria, Chronic kidney disease, Liver biopsy, Nonalcoholic fatty liver disease

Identifiers

Local EPrints ID: 447194
URI: http://eprints.soton.ac.uk/id/eprint/447194
ISSN: 0939-4753
PURE UUID: b82fff6e-e2cc-4f21-ae56-91c97fa16380
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 04 Mar 2021 17:42
Last modified: 17 Mar 2024 06:22

Export record

Altmetrics

Contributors

Author: Dan-Qin Sun
Author: Ting-Yao Wang
Author: Kenneth I. Zheng
Author: Hao-Yang Zhang
Author: Xiao-Dong Wang
Author: Giovanni Targher
Author: Yong-Ping Chen
Author: Wei-Jie Yuan
Author: Yan Jin
Author: Ming-Hua Zheng

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×